Monogram Technologies Inc (MGRM)
2.09
+0.01
(+0.48%)
USD |
NASDAQ |
Jul 05, 16:00
2.08
-0.01
(-0.48%)
After-Hours: 20:00
Monogram Technologies Research and Development Expense (Annual): 10.59M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.59M |
| December 31, 2022 | 5.385M |
| December 31, 2021 | 5.279M |
| December 31, 2020 | 4.671M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.1943M |
| December 31, 2018 | 0.0317M |
| December 31, 2017 | 0.0483M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.1943M
Minimum
2019
10.59M
Maximum
2023
5.223M
Average
5.279M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| Xtant Medical Holdings Inc | 1.336M |
| Asensus Surgical Inc | 37.02M |
| Catheter Precision Inc | 0.475M |